{"public_id":"cl_2a7af4372c2b967dfd8f498fe38f31d8","status":"active","superseded_by_public_id":null,"corpus_id":245806422,"text":"CD5-targeted lipid nanoparticles delivering modified mRNA can generate transient CAR T cells entirely inside the body.","confidence":0.98,"paper":{"corpus_id":245806422,"title":"CAR T cells produced in vivo to treat cardiac injury","url":"https://sah.borca.ai/papers/245806422"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.98,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_25a36a42bae3cf528f281db5e49c1081","name":"CAR T cells","description":"T lymphocytes engineered to express chimeric antigen receptors that enable antigen-specific recognition.","types":["cell type","therapeutic agent"],"url":"https://sah.borca.ai/concepts/co_25a36a42bae3cf528f281db5e49c1081"},{"public_id":"co_40c9cb50a0e6e2b32d56251d073e593e","name":"CD5-targeted lipid nanoparticles","description":"Lipid nanoparticle carriers designed to deliver cargo specifically to CD5-positive T lymphocytes.","types":["delivery vehicle"],"url":"https://sah.borca.ai/concepts/co_40c9cb50a0e6e2b32d56251d073e593e"},{"public_id":"co_ac18acb8a46d9950df1cb034f409eb3b","name":"modified messenger RNA","description":"Engineered mRNA used to encode the chimeric antigen receptor for transient cell reprogramming.","types":["nucleic acid","therapeutic payload"],"url":"https://sah.borca.ai/concepts/co_ac18acb8a46d9950df1cb034f409eb3b"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_2a7af4372c2b967dfd8f498fe38f31d8"}